2018 Speaking Faculty



Industry & Researcher Perspectives

John Alter
John Alter
Vice President, Patient and Health Impact
Pfizer Essential Health Business Unit


Ana Cespedes
Ana Cespedes
Senior Vice President, Global Head, Market Access and Pricing
Merck


Stephen Chang
Stephen Chang
Senior Vice President for Strategic Research Initiatives
NY Stem Cell Foundation


Ann Hartry
Ann Hartry
VP, HEOR
Lundbeck


Photo Not Available
Doug Jolly
Executive Vice President, Research and Pharmaceutical Development
Tocagen


Vikas Kundra
Vikas Kundra, MD, PhD
Director Molecular Imaging, Department of Radiology, M.D.
Anderson Cancer Center


Ed McAdam
Ed McAdam
Executive Director, Pricing and Contracting
Intarcia Therapeutics, Inc.


Morgan Molloy
Morgan Molloy
Chief Commercial Officer
Enzyvant


C. David Pauza
C. David Pauza, PhD
Chief Science Officer
American Gene Technologies


Ashish Sagrolikar
Ashish Sagrolikar
VP, Commercial Transformation
GSK


Satish Vullari
Satish Vullari
Director, US Rare Disease Patient Access
Pfizer


Reg Waldeck
Reg Waldeck
Market Access Leader
Bayer


Photo Not Available
Agnes Yeboah, PhD
Senior Director, Global Regulatory CMC – Biologics
Celgene Corporation


Gergana Zlateva
Gergana Zlateva
Patient & Health Impact, Oncology Market Access Lead
Pfizer


Key Stakeholder Perspectives

Amal Agarwal
Amal Agarwal
Medical Director
Humana


Jim Clement
Jim Clement
Executive Director, Cost of Care & Supply Chain Strategy
Aetna


Stanislav Glezer
Stanislav Glezer, MD MBA
Chief Medical Officer
Adocia


Robert Goldberg
Robert Goldberg, PhD
President and Co-Founder
Center For Medicine in Public Interest


Chris Guinther
Chris Guinther
System Director, Managed Care Pharmacy Services
Mercy Health


Lindsay McKenna
Lindsay McKenna
Associate Principal
McKinsey & Company


Edmund Pezalla
Edmund Pezalla
Former Vice President, National Medical Director, Pharmaceutical Policy and Strategy
Aetna


Lincoln Tsang
Lincoln Tsang, PhD
Partner, Life Science Practice
Arnold & Porter Kaye Scholer LLP


Grace-Marie Turner
Grace-Marie Turner
President
Galen Institute